Arcutis Biotherapeutics, Inc.
ARQT
Rang în acțiuni
#3988
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Preț acțiune
$33.19
Capitalizare de piață
$4.17B
Schimbare (1 zi)
4.06%
Schimbare (1 an)
58.93%
Țară
US
Tranzacționează Arcutis Biotherapeutics, Inc. (ARQT)
Categorie
Healthcare
Istoricul spliturilor pentru Arcutis Biotherapeutics, Inc. (ARQT)
Acțiunea Arcutis Biotherapeutics, Inc. (simbol: ARQT) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 20, 2026.
O acțiune ARQT cumpărată înainte de Oct 20, 2026 este echivalentă astăzi cu 0 acțiuni ARQT.
Cel mai recent split a avut loc pe Oct 20, 2026.
O acțiune ARQT cumpărată înainte de Oct 20, 2026 este echivalentă astăzi cu 0 acțiuni ARQT.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| Nu sunt suficiente date pentru perioada selectată. | |||
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|